Codexis is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.
|May 14, 2013|
|Codexis to Present at 2013 UBS Global Healthcare Conference|
|May 07, 2013|
|Codexis Reports First Quarter 2013 Results|
|April 29, 2013|
|Codexis to Announce First Quarter 2013 Financial Results on May 7, 2013|
|View more news >>|
|There are currently no events scheduled.|
|View more events >>|
|There are currently no items available.|
|Receive E-mail Alerts|
|You may automatically receive Codexis, Inc. financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit. The next page will display a menu of options.|
To change your e-mail options at any time, re-enter your e-mail address and click Submit, then adjust your form entries.
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.